Form D · Biotechnology
Meryx Inc.
Chapel Hill, NC · CIK 0001606031
Offering snapshot reported Jun 30, 2015 · SEC filing
- Reported sold
- $2.5M Offering amount: $2.5M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 23, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 30, 2015 | Initial | $2,500,000 | No comparison | 9 | SEC filing |
| Dec 29, 2014 | Initial | $1,544,999 | No comparison | 2 | SEC filing |
| Apr 28, 2014 | Initial | $3,100,172 | No comparison | 3 | SEC filing |
| Apr 28, 2014 | Amendment | $3,100,172 | $0vs Apr 28, 2014 | 3 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-242792
Source: Form D, filed Jun 30, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| H. Shelton Earp | Director |
| Fred Eshelman | Director |
| Stephen V. Frye | Director |
| Douglas K. Graham | Director |
| Sailash Patel | Executive |
| Seth Rudnick | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1414 Raleigh Road, Suite 445
Chapel Hill, NC, 27517
Chapel Hill, NC, 27517